World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
29421
World Ranking
2716
National Ranking
113

Koji Tamada publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Koji Tamada sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 197 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Koji Tamada D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Koji Tamada sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Koji Tamada is affiliated with Yamaguchi University in Japan and has contributed extensively to research in the fields of Medicine and Immunology and Microbiology. Their work predominantly focuses on oncology and immunology, with additional research spanning molecular biology, biomedical engineering, and genetics.

Their primary research topics encompass:

  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • Virus-based gene therapy research
  • Nanowire Synthesis and Applications

Tamada's frequent publication venues include:

  • Cancer Science
  • Cancer Immunology Immunotherapy
  • Cancer Research
  • Scientific Reports
  • Journal of Clinical Oncology

Significant recent papers authored or co-authored by Tamada include:

  • Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells, 2020, Cancer Science
  • Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells, 2022, Nature Biomedical Engineering
  • Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models, 2021, Cancer Immunology Immunotherapy
  • The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma, 2022, Cancer Immunology Immunotherapy
  • Anti-tumor efficacy of human anti-c-met CAR-T cells against papillary renal cell carcinoma in an orthotopic model, 2021, Cancer Science

Koji Tamada has collaborated frequently with several co-authors, including:

  • Yukimi Sakoda
  • Keishi Adachi
  • Shunsuke Goto
  • Yoshihiro Komohara
  • Yukio Fujiwara

Best Publications

  • Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

    Haidong Dong;Scott E. Strome;Diva R. Salomao;Hideto Tamura

  • B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

    Haidong Dong;Gefeng Zhu;Koji Tamada;Lieping Chen

  • Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

    Unknown

  • B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

    Andrei I. Chapoval;Jian Ni;Julie S. Lau;Ryan A. Wilcox

  • Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity

    Fumiya Hirano;Katsumi Kaneko;Hideto Tamura;Haidong Dong

  • B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.

    Gabriel L. Sica;In Hak Choi;In Hak Choi;Gefeng Zhu;Koji Tamada

  • IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor

    Keishi Adachi;Yosuke Kano;Tomohiko Nagai;Namiko Okuyama

  • B7-H1 Blockade Augments Adoptive T-Cell Immunotherapy for Squamous Cell Carcinoma

    Scott E. Strome;Haidong Dong;Hideto Tamura;Stephen G. Voss

  • LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response

    Koji Tamada;Koji Shimozaki;Andrei I. Chapoval;Yifan Zhai

  • B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes

    Haidong Dong;Gefeng Zhu;Koji Tamada;Dallas B. Flies

  • Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS

    Shengdian Wang;Gefeng Zhu;Andrei I. Chapoval;Haidong Dong

  • B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance

    Jang June Park;Ryusuke Omiya;Yumiko Matsumura;Yukimi Sakoda

  • Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

    Koji Tamada;Koji Shimozaki;Andrei I. Chapoval;Gefeng Zhu

  • 53BP1 is required for class switch recombination

    Irene M. Ward;Bernardo Reina-San-Martin;Alexandru Olaru;Kay Minn

  • Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family

    In Hak Choi;Gefeng Zhu;Gabriel L. Sica;Scott E. Strome

  • Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors

    Ryan A. Wilcox;Dallas B. Flies;Gefeng Zhu;Aaron J. Johnson

  • B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

    Hideto Tamura;Haidong Dong;Gefeng Zhu;Gabriel L. Sica

  • Cutting edge: Expression of functional CD137 receptor by dendritic cells.

    Ryan A. Wilcox;Andrei I. Chapoval;Kevin S. Gorski;Mizuto Otsuji

  • Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy

    Fumihiko Tsushima;Sheng Yao;Tahiro Shin;Andrew Flies

  • Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.

    H Tamura;M Ishibashi;T Yamashita;S Tanosaki

  • The regulation of T cell homeostasis and autoimmunity by T cell–derived LIGHT

    Jing Wang;James C. Lo;Amy Foster;Ping Yu

Frequent Co-Authors

Lieping Chen
Lieping Chen Yale University
Kikuo Nomoto
Kikuo Nomoto Kyushu University
Haidong Dong
Haidong Dong Mayo Clinic
Hiroaki Nagano
Hiroaki Nagano Osaka University
Larry R. Pease
Larry R. Pease Mayo Clinic
Moses Rodriguez
Moses Rodriguez Mayo Clinic
Kenji Kabashima
Kenji Kabashima Kyoto University
Yang-Xin Fu
Yang-Xin Fu Tsinghua University
Jürgen Bajorath
Jürgen Bajorath University of Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, several healthcare-related degrees offer promising career opportunities. Nursing pathways, such as Licensed Practical Nurse (LPN) programs, provide a strong foundation in patient care. Many students explore the easiest LPN programs to get into for faster entry into the nursing field.

Advancing further, Nurse Practitioner degrees become an attractive option. Programs with less competitive admissions criteria allow a smoother transition for working professionals. To explore this, check out available nurse practitioner programs with easy admission.

For those interested in mental health, specialization as a Psychiatric Mental Health Nurse Practitioner (PMHNP) is highly sought after. Discover the best PMHNP programs online known for excellent clinical placement rates and hands-on training.

Cost considerations are important when choosing a program. Fortunately, there are cheapest online PMHNP programs that provide quality education without breaking the bank.

Exploring these online degree options can complement Immunology knowledge and open diverse career pathways within healthcare.

Best Scientists Citing Koji Tamada

Trending Scientists

Recently Published Articles